HK1007435A1 - Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms - Google Patents

Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms

Info

Publication number
HK1007435A1
HK1007435A1 HK98106615A HK98106615A HK1007435A1 HK 1007435 A1 HK1007435 A1 HK 1007435A1 HK 98106615 A HK98106615 A HK 98106615A HK 98106615 A HK98106615 A HK 98106615A HK 1007435 A1 HK1007435 A1 HK 1007435A1
Authority
HK
Hong Kong
Prior art keywords
protein
cytokin
microorganisms
recombinant dna
type activity
Prior art date
Application number
HK98106615A
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal En Saint-Pier Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1007435A1 publication Critical patent/HK1007435A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK98106615A 1991-03-29 1998-06-25 Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms HK1007435A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.

Publications (1)

Publication Number Publication Date
HK1007435A1 true HK1007435A1 (en) 1999-04-09

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106615A HK1007435A1 (en) 1991-03-29 1998-06-25 Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms

Country Status (14)

Country Link
US (1) US5652123A (de)
EP (1) EP0506574B1 (de)
JP (1) JP2865423B2 (de)
AT (1) ATE130869T1 (de)
CA (1) CA2083826C (de)
DE (2) DE69206301T2 (de)
DK (1) DK0506574T3 (de)
ES (1) ES2054601T3 (de)
GR (2) GR940300052T1 (de)
HK (1) HK1007435A1 (de)
HU (2) HU217099B (de)
IE (1) IE72165B1 (de)
MD (1) MD1652G2 (de)
WO (1) WO1992017586A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
WO1994004680A1 (en) * 1992-08-21 1994-03-03 Schering Corporation Human interleukin-13
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
CA2212577C (en) * 1995-02-10 2010-06-01 Novo Nordisk A/S Bacillus proteases
DE69635608T2 (de) * 1995-02-10 2006-10-26 Novozymes A/S Bacillus proteasen
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US7507706B1 (en) 1998-12-14 2009-03-24 Genetics Institute, Llc Cytokine receptor chain
EP1268794A2 (de) 2000-04-07 2003-01-02 Heska Corporation Zusammensetzungen und verfahren die an igg aus dem hund und il-13 rezeptoren aus dem hund relatiert sind
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
ATE552850T1 (de) 2003-12-23 2012-04-15 Genentech Inc Neue anti-il 13-antikörper und verwendungen dafür
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
EP1824886B1 (de) 2004-11-17 2010-12-22 Amgen Inc. Vollständige humane monoklonale antikörper gegen il-13
US20080044420A1 (en) * 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
BRPI0616359B8 (pt) * 2005-09-30 2022-08-30 Medimmune Ltd Composição farmacêutica, processo para purificação de um anticorpo de il-13 e uso de uma composição farmacêutica contendo um anticorpo
PL3339445T3 (pl) 2006-09-08 2020-12-14 Abbvie Bahamas Ltd. Białka wiążące interleukinę 13
WO2008131376A2 (en) * 2007-04-23 2008-10-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
US8399630B2 (en) * 2008-08-20 2013-03-19 Centocor Ortho Biotech Inc. Engineered anti-IL-13 antibodies, compositions, methods and uses
GB0904214D0 (en) * 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
WO2015038884A2 (en) 2013-09-13 2015-03-19 Genentech, Inc. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
CA2921999C (en) 2013-09-13 2023-03-21 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
WO1992017586A1 (fr) 1992-10-15
JPH06500567A (ja) 1994-01-20
DK0506574T3 (da) 1996-04-09
ES2054601T1 (es) 1994-08-16
CA2083826C (en) 1999-04-27
CA2083826A1 (en) 1992-09-30
DE506574T1 (de) 1994-11-17
MD970099A (en) 1998-04-30
EP0506574A1 (de) 1992-09-30
DE69206301D1 (de) 1996-01-11
ATE130869T1 (de) 1995-12-15
US5652123A (en) 1997-07-29
MD1652F2 (en) 2001-04-30
MD1652G2 (ro) 2001-12-31
IE921016A1 (en) 1992-10-07
HU9203753D0 (en) 1993-03-29
JP2865423B2 (ja) 1999-03-08
ES2054601T3 (es) 1996-04-01
IE72165B1 (en) 1997-03-26
GR3019043T3 (en) 1996-05-31
GR940300052T1 (en) 1994-08-31
DE69206301T2 (de) 1996-06-13
HU217099B (hu) 1999-11-29
EP0506574B1 (de) 1995-11-29
HUT68162A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
GR3019043T3 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
AU7587696A (en) Differentiation-suppressive polypeptide
IL68790A (en) Polydeoxyribonucleotide coding for ifn-alpha2(arg),plasmid containing it,cloning of said plasmid and microorganisms containing it and ifn-alpha(arg)encoded by said polydeoxyribonucleotide and its preparation
EP0769554A3 (de) Menschliches CNP-Gen und Vorläuferprotein
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
AU1384995A (en) Human circulating cytokine cc-1
CA2253006A1 (en) .beta.-carotene hydroxylase gene
AU5520390A (en) Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
AU7508694A (en) Novel tyrosine kinase
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
SG109959A1 (en) 5-substituted hydantoin recemase, dna coding for the same, recombinant dna, transformed cells, and process for producing optically active amino acids
EP0384731A3 (de) Osteogenische Wachstumfaktoren, die aus sich regenerierendem Knochenmark identifiziert werden
AU2043597A (en) Human taki dna encoding the same
EP0723016A3 (de) Leukocyten-aktivierender Faktor
CA2089111A1 (en) Smooth muscle mitogen and isolated dna coding therefor
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
CA2244928A1 (en) Dna coding for serine/threonine kinase
EP1013665A4 (de) Neue polypeptide mit wasserkanalaktivität und dna sequenzen
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
WO2000074629A3 (fr) Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
AU5964398A (en) Novel mouse cxc chemokine receptor
EP0845536A3 (de) Protein mit Ethylendiamine-N,N'-Dibarnsteinsäure: Ethylendiamin Lyase Aktivität und dafür kodierendes Gen

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20120326